Furthermore, Pastor et al. report the H1e haplotype to be present in 16% of PSP patients but not in controls, suggesting that SNVs in CRHR1, IMP3, MAPT or STH may be risk factors for PSP [38]. This evidence concerns the gene MAPT and supranuclear palsy, progressive, 1.